1-6 of 6
Michael Jones
Close
Sort by
Journal Articles

Profiling the E3 Ubiquitin Ligase Landscape in Normal and Sickle Red Blood Cells

Augustina Frimpong, Francisco Garcia, Chien-Hsiang Hsu, Michael Jones, Ning Guo, Hongjing Xia, Kevin Xie, Pamela Ting, Yi Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 11096.
https://doi.org/10.1182/blood-2022-163265
Published: 2022
Journal Articles

Definitive radiotherapy for localized follicular lymphoma staged by 18 F-FDG PET-CT: a collaborative study by ILROG

Clinical Trials & Observations
Jessica L. Brady, Michael S. Binkley, Carla Hajj, Monica Chelius, Karen Chau, Alex Balogh, Mario Levis, Andrea Riccardo Filippi, Michael Jones, Michael Mac Manus, Andrew Wirth, Masahiko Oguchi, Anders Krog Vistisen, Therese Youssef Andraos, Andrea K. Ng, Berthe M. P. Aleman, Seo Hee Choi, Youlia Kirova, Sara Hardy, Gabriele Reinartz, Hans T. Eich, Scott V. Bratman, Louis S. Constine, Chang-Ok Suh, Bouthaina Dabaja, Tarec C. El-Galaly, David C. Hodgson, Umberto Ricardi, Joachim Yahalom, Richard T. Hoppe, N. George Mikhaeel
Journal: Blood
Blood (2019) 133 (3): 237–245.
https://doi.org/10.1182/blood-2018-04-843540
Published: 2019
Includes: Supplemental data
Journal Articles

Proposed Biosimilar Pegfilgrastim (LA-EP2006) and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients with Breast Cancer: A Randomized, Double-Blind Trial. Protect 2: Pegfilgrastim Randomized Oncology (supportive care) Trial to Evaluate Comparative Treatment Results

Kimberley Blackwell, Ruslan Paltuev, Roman Donskih, Olga Burdaeva, Elena Bit-Sava, Tanveer Maksud, Michael Jones, Allen Nixon, Maria J Vidal, Roumen Nakov, Pritba Singh, Gregor Schaffer, Pere Gascon, Nadia Harbeck
Journal: Blood
Blood (2015) 126 (23): 632.
https://doi.org/10.1182/blood.V126.23.632.632
Published: 2015
Journal Articles

miRNA Predictors of Response to DNA Methyltransferase Inhibitors

Amma Bosompem, MS, Yan Guo, PhD, Sanjay Mohan, MD, Begum Erdogan, MA, Muhammad Raza, MD, C. Michael Jones, MD FACP, Elizabeth A. Griffiths, MD, Annette S. Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1913.
https://doi.org/10.1182/blood.V124.21.1913.1913
Published: 2014
Journal Articles

Clinical Impact of Unregulated Terminal Complement Activity in Never-Transfused Patients with Paroxysmal Nocturnal Hemoglobinuria.

Petra Muus, MD, PhD, Antonio M. Risitano, MD, PhD, H.R. Castro-Malaspina, MD, C. Michael Jones, MD, FACP, Stephen Fuller, MD, Gerard Socie, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4029.
https://doi.org/10.1182/blood.V114.22.4029.4029
Published: 2009
Journal Articles

A Prospective Analysis of Adverse Events in a Phase 2 Trial of Imatinib in the Treatment of Polycythemia Vera.

C. Michael Jones, MD, Tina M. Dickinson, MSN, FNP
Journal: Blood
Blood (2005) 106 (11): 4951.
https://doi.org/10.1182/blood.V106.11.4951.4951
Published: 2005